Compare Alnylam Pharmaceuticals, Inc. (ALNY) vs Toyota Motor Corp (TM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alnylam Pharmaceuticals, Inc. vs Toyota Motor Corp — how do they compare? Alnylam Pharmaceuticals, Inc. trades at $220.34 (market cap $29.60B), while Toyota Motor Corp trades at $189.04 (market cap $221.79B). The key difference: Toyota Motor Corp is far larger — about 7.5× Alnylam Pharmaceuticals, Inc.'s market cap, and Toyota Motor Corp pays a 3.3% dividend while Alnylam Pharmaceuticals, Inc. pays none. Which is the better fit depends on your goals.
| ALNY | TM | |
|---|---|---|
Market Cap | $29.60B | $221.79B |
Sector | Health | Consumer Cyclical |
52-Week High | $491.22 | $248.29 |
52-Week Low | $205.48 | $166.50 |
Enterprise Value | $27.56B | $414.06B |
Dividend Yield | — | 3.3% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia.
Read more on ALNY →About Toyota Motor Corp
Founded in 1937, Toyota is one of the world's largest automakers with 10.38 million units sold at retail in fiscal 2022 across its light vehicle brands. Brands include Toyota, Lexus, Daihatsu, and truck maker Hino.
Read more on TM →
